Bill Text — Jan 20, 2015
This bill’s text is now available.
Aug 2, 2013
113th Congress, 2013–2015
This bill was introduced on August 2, 2013, in a previous session of Congress, but was not enacted.
Representative for Utah's 3rd congressional district
Read Text »
Last Updated: Aug 2, 2013
Length: 5 pages
To amend section 505 of the Federal Food, Drug, and Cosmetic Act to provide incentives for the development of new combination drugs.
8/2/2013--Introduced.Combination Drug Development Incentive Act of 2013 - Amends the Federal Food, Drug, and Cosmetic Act with respect to the five-year bar on a new drug application (or abbreviated drug ... Read more >
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
Reintroduced Bill — Introduced
This activity took place on a related bill, H.R. 406.
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 2985”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 2985 — 113th Congress: Combination Drug Development Incentive Act of 2013. Retrieved from https://www.govtrack.us/congress/bills/113/hr2985
“H.R. 2985 — 113th Congress: Combination Drug Development Incentive Act of 2013.” www.GovTrack.us. 2013. December 1, 2015 <https://www.govtrack.us/congress/bills/113/hr2985>
|title=H.R. 2985 (113th)
|accessdate=December 1, 2015
|author=113th Congress (2013)
|date=August 2, 2013
|quote=Combination Drug Development Incentive Act of 2013